SlideShare une entreprise Scribd logo
1  sur  22
Biotec Services International


John Shaw

John.shaw@biotec-uk.com
Business Development Manager
Who are Biotec?
Your company of choice for temperature controlled pharmaceutical services. Through
experience gained from over 15 years in the clinical supply arena, Biotec have
assembled a team of dedicated professionals to ensure that every project we manage on
your behalf is ‘In Safe Hands’ from initiation to completion.

Background
•   Founded in 1997
•   Privately owned
•   Split-site, purpose built GMP facilities licensed by the MHRA
•   Queen’s Award for Enterprise 2009
Product Experience
Classification               Product type
Biologics                    Monoclonal antibodies
                             Therapeutic proteins
                             Vaccines
                             Viruses
Advanced Therapy Medicinal   Stem cells
Products                     Gene therapies (GMO Biosafety level II)
                             Tissue engineered products
Small molecules              Oral
                             Injectable
                             Topical
                             Inhalation
Controlled drugs             Schedules 2 to 4
Devices                      Patient use
                             Surgical use
QP & GMP Consultancy
•   Eight QPs with wide experience of Biotec’s core service areas

•   Advice to ensure speedy transition through regulatory hurdles utilizing
    Biotec’s unique ‘Product Supply Route Map’

•   QP audits & familiarisation visits for IMP and Marketed Product importation
    providing a smooth path to release

•   Expert knowledge regarding:
    • EU regulatory requirements
    • Label text compliance
    • Blinding issues
Clinical Supplies
•   Comprehensive clinical trials supply service by combining:
    • In-house capabilities and expertise
    • Services of expert partners where appropriate

•   Currently serve over 35 clients with one or more clinical
    projects – Phase I to III

•   Global supply
    • Customer base spanning from West Coast USA to Asia
      Pacific
    • Staff adept at handling multi-national, multi-cultural
      trials
Clinical Supplies
•   Management of unlicensed medicines through Biotec’s Specials supply service
    • Manufacturer Specials Licence MS/19819
    • Continuation of supply to patients for compassionate use

•   Biotec’s experienced Project Management team advantage
    • An average of 14 years industry experience
    • Extensive knowledge of handling challenging products and clinical trials
    • A flexible approach to reporting activities – tailored to client requirements
    • Established team who strive to develop the relationship and stay with the client
      throughout future projects
Global Logistics
•   Expert logistics team take control to reduce risk to client, patient and product
    • Handle shipping declarations and import/export documentation
    • Site specific advice available via ‘In Safe Hands’ video and proactive
      communication

•   Qualified shipping systems from ambient temperature to vapour phase nitrogen
    • Vast experience in handling ultra low temperature materials
    • Product specific qualification of shippers & transport systems if required

•   Range of temperature monitoring options available to meet specific requirements

•   Utilisation of partner depot network for global supply
    • 23 depots in key geographical locations
Global Logistics
GMP Temperature Controlled
Storage
•   Proven track record of successful long term storage for
    biological (up to Biosafety level 2), controlled drug
    (Schedule 2 to 4), clinical and retain materials

•   Flexible approach to storage offering single sample
    through to pallet size options at a range of temperatures

•   Dual site storage managed via one point of contact

•   ‘Rapid Response Service’ - reactive to expedited
    shipment requests to ensure that material is transferred
    rapidly
Advanced Therapy Medicinal
Products
•   Over 10 years experience handling ATMPs
•   Proven track record handling ultra low temperature
    material
•   Technical support team to advise on specific product
    handling options
•   Constant review of new technology to improve
    Biotec’s service offering
Commercial Services
•   Managed through Biotec’s wholesaler Dealers licence

•   Dedicated team to manage commercial product storage and distribution

•   Commercial supply activities segregated from clinical projects

•   Strategy is to focus on niche products
    • Hospital supply
    • Orphan drugs
    • Difficult to handle, temperature sensitive products

•   Expedited dispatch and global market delivery
The Biotec Approach
….at Biotec          Strategy
Communication        Committed team who understand the clients needs
                     Low staff turnover – retention of client preferences
                     Flexible team to ensure all clients are offered a premium service
Project Management   Dedicated Project Manager assigned to each customer
                     First point of call for queries
                     Work in partnership to achieve project goals
Expertise            Experienced management, operational and Quality teams
                     Large proportion of repeat business from a global client base
                     Extensive experience with difficult to handle products
Forward Thinking     Investment to meet client needs
                     Focus on continuous improvement
Biotec Facilities (Capacity)

   Capacity                      Biotec House          Bio2tec
   Facility size                 14,000 ft2            10,000 ft2
   General warehousing           86 pallets            30 pallets
   Controlled ambient            26 pallets            150 pallets
   2-8°C                         20 pallets            80 pallets plus
                                                       20,000 kits
   -20°C                         800 kits              50 pallets 2,000 kits
   -80°C                         340,000 vial          -
                                 locations
   Liquid/vapour phase nitrogen 27 x 40 litre dewars
Biotec Presentation 27 March 2012

Contenu connexe

Tendances

Good warehousing practices by RK Koduru
Good warehousing practices  by RK KoduruGood warehousing practices  by RK Koduru
Good warehousing practices by RK KoduruRK Koduru
 
MATERIAL MANAGEMENT QUALITY ASSURANCE TECHNIQUE
MATERIAL MANAGEMENT QUALITY ASSURANCE TECHNIQUEMATERIAL MANAGEMENT QUALITY ASSURANCE TECHNIQUE
MATERIAL MANAGEMENT QUALITY ASSURANCE TECHNIQUESalmanLatif14
 
Mannatech’s Global Commitment to Quality Products
Mannatech’s Global Commitment to Quality ProductsMannatech’s Global Commitment to Quality Products
Mannatech’s Global Commitment to Quality ProductsDREAMTEAM Run to Platinum
 
GMP of ASU Drugs
GMP of ASU DrugsGMP of ASU Drugs
GMP of ASU DrugsAkhtar Ali
 
Jan Cortenbach: Future arrangements on feed safety and quality
Jan Cortenbach: Future arrangements on feed safety and qualityJan Cortenbach: Future arrangements on feed safety and quality
Jan Cortenbach: Future arrangements on feed safety and qualityVIV Corporate
 
Schedule m(gmp)
Schedule m(gmp)Schedule m(gmp)
Schedule m(gmp)air981
 
Apresentação cipan sbe ist_2016_4(post link_in)
Apresentação cipan sbe ist_2016_4(post link_in)Apresentação cipan sbe ist_2016_4(post link_in)
Apresentação cipan sbe ist_2016_4(post link_in)Manuel Eduardo Fernandes
 
Custody Chain CASI vision to Combat Food Fraud
Custody Chain CASI vision to Combat Food FraudCustody Chain CASI vision to Combat Food Fraud
Custody Chain CASI vision to Combat Food FraudPrimority Ltd
 

Tendances (15)

Good warehousing practices by RK Koduru
Good warehousing practices  by RK KoduruGood warehousing practices  by RK Koduru
Good warehousing practices by RK Koduru
 
MATERIAL MANAGEMENT QUALITY ASSURANCE TECHNIQUE
MATERIAL MANAGEMENT QUALITY ASSURANCE TECHNIQUEMATERIAL MANAGEMENT QUALITY ASSURANCE TECHNIQUE
MATERIAL MANAGEMENT QUALITY ASSURANCE TECHNIQUE
 
PPC Brochure
PPC BrochurePPC Brochure
PPC Brochure
 
Challenges of Cold Chain Supply
Challenges of Cold Chain SupplyChallenges of Cold Chain Supply
Challenges of Cold Chain Supply
 
Mannatech’s Global Commitment to Quality Products
Mannatech’s Global Commitment to Quality ProductsMannatech’s Global Commitment to Quality Products
Mannatech’s Global Commitment to Quality Products
 
GMP of ASU Drugs
GMP of ASU DrugsGMP of ASU Drugs
GMP of ASU Drugs
 
Multivac
MultivacMultivac
Multivac
 
Multivac Medical
Multivac MedicalMultivac Medical
Multivac Medical
 
Jan Cortenbach: Future arrangements on feed safety and quality
Jan Cortenbach: Future arrangements on feed safety and qualityJan Cortenbach: Future arrangements on feed safety and quality
Jan Cortenbach: Future arrangements on feed safety and quality
 
Design of warehouse
Design of warehouseDesign of warehouse
Design of warehouse
 
Schedule m(gmp)
Schedule m(gmp)Schedule m(gmp)
Schedule m(gmp)
 
PharmaSynth Biopharmaceutical Manufacturing Services
PharmaSynth Biopharmaceutical Manufacturing ServicesPharmaSynth Biopharmaceutical Manufacturing Services
PharmaSynth Biopharmaceutical Manufacturing Services
 
Apresentação cipan sbe ist_2016_4(post link_in)
Apresentação cipan sbe ist_2016_4(post link_in)Apresentação cipan sbe ist_2016_4(post link_in)
Apresentação cipan sbe ist_2016_4(post link_in)
 
Food logistic
Food logisticFood logistic
Food logistic
 
Custody Chain CASI vision to Combat Food Fraud
Custody Chain CASI vision to Combat Food FraudCustody Chain CASI vision to Combat Food Fraud
Custody Chain CASI vision to Combat Food Fraud
 

En vedette

Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Ravs100
 
Los coches mas_caros-2446
Los coches mas_caros-2446Los coches mas_caros-2446
Los coches mas_caros-2446benediego
 
Korte Acta Bedrijfspresentatie 2011
Korte Acta Bedrijfspresentatie 2011Korte Acta Bedrijfspresentatie 2011
Korte Acta Bedrijfspresentatie 2011schunselaar
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Ravs100
 
Barisan dan deret aritmatika
Barisan dan deret aritmatikaBarisan dan deret aritmatika
Barisan dan deret aritmatikarapidawati
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation LinkedinRavs100
 
Comunication khairul
Comunication khairulComunication khairul
Comunication khairulakmalfiraz
 
Breakdown and timings
Breakdown and timingsBreakdown and timings
Breakdown and timingsterrylcooper
 
Pert 7 teori probabilitas
Pert 7  teori probabilitasPert 7  teori probabilitas
Pert 7 teori probabilitasOhan Handiyanto
 

En vedette (16)

Aztec project
Aztec projectAztec project
Aztec project
 
Goodwins Theory
Goodwins TheoryGoodwins Theory
Goodwins Theory
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012
 
Los coches mas_caros-2446
Los coches mas_caros-2446Los coches mas_caros-2446
Los coches mas_caros-2446
 
Korte Acta Bedrijfspresentatie 2011
Korte Acta Bedrijfspresentatie 2011Korte Acta Bedrijfspresentatie 2011
Korte Acta Bedrijfspresentatie 2011
 
Goodwin's Theory
Goodwin's TheoryGoodwin's Theory
Goodwin's Theory
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012
 
Opening
OpeningOpening
Opening
 
Video plans
Video plansVideo plans
Video plans
 
Barisan dan deret aritmatika
Barisan dan deret aritmatikaBarisan dan deret aritmatika
Barisan dan deret aritmatika
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedin
 
Comunication khairul
Comunication khairulComunication khairul
Comunication khairul
 
First Ideas
First IdeasFirst Ideas
First Ideas
 
Breakdown and timings
Breakdown and timingsBreakdown and timings
Breakdown and timings
 
Sombreros
SombrerosSombreros
Sombreros
 
Pert 7 teori probabilitas
Pert 7  teori probabilitasPert 7  teori probabilitas
Pert 7 teori probabilitas
 

Similaire à Biotec Presentation 27 March 2012

Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012tony_street
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012biotec_fiona
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation LinkedinMatthewLakelin
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedinbiotec_rachel
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedinbiotec_fiona
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedinbiotec_paul
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedinbiotec_amanda
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedintrisevans
 
Supply chain process of Martin Dow Limited
Supply chain process of Martin Dow LimitedSupply chain process of Martin Dow Limited
Supply chain process of Martin Dow LimitedMuhammad Umer
 
Cavalier Pharma Logistics Group Capabilities & IQP Overview winyard2015
Cavalier Pharma Logistics Group Capabilities & IQP  Overview winyard2015Cavalier Pharma Logistics Group Capabilities & IQP  Overview winyard2015
Cavalier Pharma Logistics Group Capabilities & IQP Overview winyard2015Stephen D. Winyard
 
Presentation Of Capabilities Elf
Presentation Of Capabilities   ElfPresentation Of Capabilities   Elf
Presentation Of Capabilities ElfEmma Lee
 
Bilcare gcs leaflet
Bilcare gcs leafletBilcare gcs leaflet
Bilcare gcs leafletBilcareltd
 
Dcn inovatec presentation final
Dcn inovatec presentation finalDcn inovatec presentation final
Dcn inovatec presentation finalFabiana Tarabal
 
Recipharm Development Services May 2015
Recipharm Development Services May 2015Recipharm Development Services May 2015
Recipharm Development Services May 2015Sylvia Kachalsky
 
Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...
Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...
Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...Cell and Gene Therapy Catapult
 
Dcninovatecpresentationfinal 101110124949-phpapp01
Dcninovatecpresentationfinal 101110124949-phpapp01Dcninovatecpresentationfinal 101110124949-phpapp01
Dcninovatecpresentationfinal 101110124949-phpapp01Fabiana Tarabal
 
Key Considerations & Case Study for Building a cGMP Biomanufacturing Facility
Key Considerations & Case Study for Building a cGMP Biomanufacturing FacilityKey Considerations & Case Study for Building a cGMP Biomanufacturing Facility
Key Considerations & Case Study for Building a cGMP Biomanufacturing FacilityMerck Life Sciences
 
Key Considerations & Case Study for Building a cGMP Biomanufacturing Facility
Key Considerations & Case Study for Building a cGMP Biomanufacturing FacilityKey Considerations & Case Study for Building a cGMP Biomanufacturing Facility
Key Considerations & Case Study for Building a cGMP Biomanufacturing FacilityMilliporeSigma
 

Similaire à Biotec Presentation 27 March 2012 (20)

Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedin
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedin
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedin
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedin
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedin
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedin
 
Supply chain process of Martin Dow Limited
Supply chain process of Martin Dow LimitedSupply chain process of Martin Dow Limited
Supply chain process of Martin Dow Limited
 
Stabicon Corporate Presentation
Stabicon Corporate PresentationStabicon Corporate Presentation
Stabicon Corporate Presentation
 
Stabicon-Corporate presentation
Stabicon-Corporate presentationStabicon-Corporate presentation
Stabicon-Corporate presentation
 
Cavalier Pharma Logistics Group Capabilities & IQP Overview winyard2015
Cavalier Pharma Logistics Group Capabilities & IQP  Overview winyard2015Cavalier Pharma Logistics Group Capabilities & IQP  Overview winyard2015
Cavalier Pharma Logistics Group Capabilities & IQP Overview winyard2015
 
Presentation Of Capabilities Elf
Presentation Of Capabilities   ElfPresentation Of Capabilities   Elf
Presentation Of Capabilities Elf
 
Bilcare gcs leaflet
Bilcare gcs leafletBilcare gcs leaflet
Bilcare gcs leaflet
 
Dcn inovatec presentation final
Dcn inovatec presentation finalDcn inovatec presentation final
Dcn inovatec presentation final
 
Recipharm Development Services May 2015
Recipharm Development Services May 2015Recipharm Development Services May 2015
Recipharm Development Services May 2015
 
Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...
Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...
Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...
 
Dcninovatecpresentationfinal 101110124949-phpapp01
Dcninovatecpresentationfinal 101110124949-phpapp01Dcninovatecpresentationfinal 101110124949-phpapp01
Dcninovatecpresentationfinal 101110124949-phpapp01
 
Key Considerations & Case Study for Building a cGMP Biomanufacturing Facility
Key Considerations & Case Study for Building a cGMP Biomanufacturing FacilityKey Considerations & Case Study for Building a cGMP Biomanufacturing Facility
Key Considerations & Case Study for Building a cGMP Biomanufacturing Facility
 
Key Considerations & Case Study for Building a cGMP Biomanufacturing Facility
Key Considerations & Case Study for Building a cGMP Biomanufacturing FacilityKey Considerations & Case Study for Building a cGMP Biomanufacturing Facility
Key Considerations & Case Study for Building a cGMP Biomanufacturing Facility
 

Biotec Presentation 27 March 2012

  • 1.
  • 2. Biotec Services International John Shaw John.shaw@biotec-uk.com Business Development Manager
  • 3. Who are Biotec? Your company of choice for temperature controlled pharmaceutical services. Through experience gained from over 15 years in the clinical supply arena, Biotec have assembled a team of dedicated professionals to ensure that every project we manage on your behalf is ‘In Safe Hands’ from initiation to completion. Background • Founded in 1997 • Privately owned • Split-site, purpose built GMP facilities licensed by the MHRA • Queen’s Award for Enterprise 2009
  • 4. Product Experience Classification Product type Biologics Monoclonal antibodies Therapeutic proteins Vaccines Viruses Advanced Therapy Medicinal Stem cells Products Gene therapies (GMO Biosafety level II) Tissue engineered products Small molecules Oral Injectable Topical Inhalation Controlled drugs Schedules 2 to 4 Devices Patient use Surgical use
  • 5.
  • 6.
  • 7. QP & GMP Consultancy • Eight QPs with wide experience of Biotec’s core service areas • Advice to ensure speedy transition through regulatory hurdles utilizing Biotec’s unique ‘Product Supply Route Map’ • QP audits & familiarisation visits for IMP and Marketed Product importation providing a smooth path to release • Expert knowledge regarding: • EU regulatory requirements • Label text compliance • Blinding issues
  • 8.
  • 9. Clinical Supplies • Comprehensive clinical trials supply service by combining: • In-house capabilities and expertise • Services of expert partners where appropriate • Currently serve over 35 clients with one or more clinical projects – Phase I to III • Global supply • Customer base spanning from West Coast USA to Asia Pacific • Staff adept at handling multi-national, multi-cultural trials
  • 10. Clinical Supplies • Management of unlicensed medicines through Biotec’s Specials supply service • Manufacturer Specials Licence MS/19819 • Continuation of supply to patients for compassionate use • Biotec’s experienced Project Management team advantage • An average of 14 years industry experience • Extensive knowledge of handling challenging products and clinical trials • A flexible approach to reporting activities – tailored to client requirements • Established team who strive to develop the relationship and stay with the client throughout future projects
  • 11.
  • 12. Global Logistics • Expert logistics team take control to reduce risk to client, patient and product • Handle shipping declarations and import/export documentation • Site specific advice available via ‘In Safe Hands’ video and proactive communication • Qualified shipping systems from ambient temperature to vapour phase nitrogen • Vast experience in handling ultra low temperature materials • Product specific qualification of shippers & transport systems if required • Range of temperature monitoring options available to meet specific requirements • Utilisation of partner depot network for global supply • 23 depots in key geographical locations
  • 14.
  • 15. GMP Temperature Controlled Storage • Proven track record of successful long term storage for biological (up to Biosafety level 2), controlled drug (Schedule 2 to 4), clinical and retain materials • Flexible approach to storage offering single sample through to pallet size options at a range of temperatures • Dual site storage managed via one point of contact • ‘Rapid Response Service’ - reactive to expedited shipment requests to ensure that material is transferred rapidly
  • 16.
  • 17. Advanced Therapy Medicinal Products • Over 10 years experience handling ATMPs • Proven track record handling ultra low temperature material • Technical support team to advise on specific product handling options • Constant review of new technology to improve Biotec’s service offering
  • 18.
  • 19. Commercial Services • Managed through Biotec’s wholesaler Dealers licence • Dedicated team to manage commercial product storage and distribution • Commercial supply activities segregated from clinical projects • Strategy is to focus on niche products • Hospital supply • Orphan drugs • Difficult to handle, temperature sensitive products • Expedited dispatch and global market delivery
  • 20. The Biotec Approach ….at Biotec Strategy Communication Committed team who understand the clients needs Low staff turnover – retention of client preferences Flexible team to ensure all clients are offered a premium service Project Management Dedicated Project Manager assigned to each customer First point of call for queries Work in partnership to achieve project goals Expertise Experienced management, operational and Quality teams Large proportion of repeat business from a global client base Extensive experience with difficult to handle products Forward Thinking Investment to meet client needs Focus on continuous improvement
  • 21. Biotec Facilities (Capacity) Capacity Biotec House Bio2tec Facility size 14,000 ft2 10,000 ft2 General warehousing 86 pallets 30 pallets Controlled ambient 26 pallets 150 pallets 2-8°C 20 pallets 80 pallets plus 20,000 kits -20°C 800 kits 50 pallets 2,000 kits -80°C 340,000 vial - locations Liquid/vapour phase nitrogen 27 x 40 litre dewars